Wu Ching-Feng, Hsieh Ming-Ju, Liu Hung-Pin, Gonzalez-Rivas Diego, Liu Yun-Hen, Wu Yi-Cheng, Chao Yin-Kai, Wu Ching-Yang
1 Chang Gung University, Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Taiwan ; 2 Chang Gung University, Department of Anesthesia, Chang Gung Memorial Hospital, Linkou, Taiwan ; 3 Department of Thoracic Surgery, Coruña University Hospital; Minimally Invasive Thoracic Surgery Unit (UCTMI), Coruña, Spain.
J Thorac Dis. 2016 Jun;8(6):1087-93. doi: 10.21037/jtd.2016.04.01.
The establishment of a golden standard for post-operative analgesia after thoracic surgery remains an unresolved issue. Benefiting from the rapid development of single port video-assisted thoracoscopic surgery (VATS), a good candidate for the alleviation of patients' pain is the placement of an intercostal catheter (ICC) safely after uniport VATS. We hypothesized that continual infusion through ICC could provide effective analgesia for patients with only one wound and we evaluate its postoperative analgesic function in uniport VATS patients with or without intercostal nerve blockade.
Since March 2014, 235 patients received various kinds of single port VATS. We identified 50 patients who received single port VATS with intercostal nerve blockade and retrospectively compared them with a group of patients who had received single port VATS without intercostal nerve blockade. The operative time, post operation day 0, 1, 2, 3 and discharge day pain score, narcotic requirements, drainage duration and post-operative hospital stay were collected. In order to establish a well-balanced cohort study, we also used propensity scores matching (1:1) to compare the short term clinical outcome in two groups.
No operative deaths occurred in this study. The uniport VATS with intercostal nerve blockade group was associated with less post operation day 0 and day 1 pain score, and narcotic requirements in our cohort study (P<0.001, <0.001, and 0.003). After propensity scores matching, there were 50 patients in each group. Mean day 0 and day 1, day 2, day 3 pain score, drainage duration, post-operative hospital stay, and narcotic requirements were smaller in uniport VATS with intercostal nerve blockade (P<0.001, <0.001, 0.038, 0.007, 0.02, 0.042, and 0.003).
In conclusion, in patients post single port VATS, continual intercostal nerve block with levobupivacaine infusion appears to be a safe, effective and promising technique in our study, associated with a shorter hospital stay and less post-operative pain. Further prospective trials are needed to determine the long term outcomes.
胸外科术后镇痛金标准的建立仍是一个未解决的问题。受益于单孔电视辅助胸腔镜手术(VATS)的快速发展,单孔VATS术后安全放置肋间导管(ICC)是缓解患者疼痛的一个良好选择。我们假设通过ICC持续输注可为仅有一个伤口的患者提供有效的镇痛,并评估其在接受或未接受肋间神经阻滞的单孔VATS患者中的术后镇痛功能。
自2014年3月以来,235例患者接受了各种单孔VATS手术。我们确定了50例接受单孔VATS并进行肋间神经阻滞的患者,并将他们与一组接受单孔VATS但未进行肋间神经阻滞的患者进行回顾性比较。收集手术时间、术后第0、1、2、3天及出院日的疼痛评分、麻醉药物需求量、引流持续时间和术后住院时间。为了建立一个均衡的队列研究,我们还使用倾向评分匹配(1:1)来比较两组的短期临床结果。
本研究未发生手术死亡。在我们的队列研究中,接受肋间神经阻滞的单孔VATS组术后第0天和第1天的疼痛评分及麻醉药物需求量较低(P<0.001、<0.001和0.003)。倾向评分匹配后,每组有50例患者。接受肋间神经阻滞的单孔VATS组术后第0天、第1天、第2天、第3天的平均疼痛评分、引流持续时间、术后住院时间及麻醉药物需求量均较低(P<0.001、<0.001、0.038、0.007、0.02、0.利用布比卡因持续肋间神经阻滞似乎是一种安全、有效且有前景的技术,与较短的住院时间和较少的术后疼痛相关。需要进一步的前瞻性试验来确定长期结果。